Organoid Transplantation: New Avenues to Treat Short Bowel Syndrome
- PMID: 34591815
- DOI: 10.1097/TP.0000000000003833
Organoid Transplantation: New Avenues to Treat Short Bowel Syndrome
Comment on
-
An organoid-based organ-repurposing approach to treat short bowel syndrome.Nature. 2021 Apr;592(7852):99-104. doi: 10.1038/s41586-021-03247-2. Epub 2021 Feb 24. Nature. 2021. PMID: 33627870
References
-
- Massironi S, Cavalcoli F, Rausa E, et al. Understanding short bowel syndrome: current status and future perspectives. Dig Liver Dis. 2020;52:253–261.
-
- Kaufman SS, Avitzur Y, Beath SV, et al. New insights into the indications for intestinal transplantation: consensus in the year 2019. Transplantation. 2020;104:937–946.
-
- O’Keefe SJD, Buchman AL, Fishbein TM, et al. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol. 2006;4:6–10.
-
- Jeppesen PB. Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. Therap Adv Gastroenterol. 2012;5:159–171.
-
- Lauro A, Lacaille F. Short bowel syndrome in children and adults: from rehabilitation to transplantation. Expert Rev Gastroenterol Hepatol. 2019;13:55–70.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources